Benzodiazepine & nonbenzodiazepine prescriptions for Taiwanese elderly with type 2 diabetes contributes to cognitive dysfunction

International Psychogeriatrics

Volumn 26, Issue 10, 2014, Pages 1719-1727

  Lai, Yung Rung ^a   Yang, Yi Sun ^a,b   Tsai, Min Ling ^a   Huang, Chien Ning ^a,b   Chiou, Jeng Yuan ^b  

^a CHUNG SHAN MEDICAL UNIVERSITY HOSPITAL   (Taiwan)

^b CHUNG SHAN MEDICAL UNIVERSITY   (Taiwan)

Author keywords

benzodiazepines; cognition disorders; elderly; hypnotics and sedatives; nonbenzodiazepine; type 2 diabetes mellitus

Indexed keywords

BENZODIAZEPINE DERIVATIVE; HYPNOTIC SEDATIVE AGENT; NONBENZODIAZEPINE DERIVATIVE; UNCLASSIFIED DRUG;

AGED; ARTICLE; COGNITIVE DEFECT; COMORBIDITY; CONTROLLED STUDY; CROSS-SECTIONAL STUDY; DEMOGRAPHY; DIABETIC PATIENT; DISEASE ASSOCIATION; DRUG SAFETY; EDUCATIONAL STATUS; ELDERLY CARE; FEMALE; HEALTH SURVEY; HIGH RISK POPULATION; HUMAN; INAPPROPRIATE PRESCRIBING; MAJOR CLINICAL STUDY; MALE; MENTAL FUNCTION ASSESSMENT; MINI MENTAL STATE EXAMINATION; NON INSULIN DEPENDENT DIABETES MELLITUS; PATIENT MONITORING; POPULATION RESEARCH; RISK FACTOR; TAIWAN; TAIWANESE; CASE CONTROL STUDY; CHEMICALLY INDUCED; COGNITION DISORDERS; COMPLICATION; NEUROPSYCHOLOGICAL TEST; STATISTICAL MODEL;

AGED; BENZODIAZEPINES; CASE-CONTROL STUDIES; COGNITION DISORDERS; CROSS-SECTIONAL STUDIES; DIABETES MELLITUS, TYPE 2; FEMALE; HUMANS; HYPNOTICS AND SEDATIVES; LOGISTIC MODELS; MALE; NEUROPSYCHOLOGICAL TESTS; RISK FACTORS; TAIWAN;

EID: 84931559841     PISSN: 10416102     EISSN: 1741203X     Source Type: Journal    
DOI: 10.1017/S1041610214000908     Document Type: Article

References (33)

1. American Geriatrics Society Beers Criteria Update Expert, P. (2012). American Geriatrics Society updated Beers Criteria for potentially inappropriate medication use in older adults. Journal of the American Geriatrics Society, 60, 616-631. doi: 10.1111/j.1532-5415.2012.03923.x.
2. Awad, N., Gagnon, M. and Messier, C. (2004). The relationship between impaired glucose tolerance, type 2 diabetes, and cognitive function. Journal of Clinical and Experimental Neuropsychology, 26, 1044-1080. doi: 10.1080/13803390490514875
3. Biessels, G. J., Staekenborg, S., Brunner, E., Brayne, C. and Scheltens, P. (2006). Risk of dementia in diabetes mellitus: a systematic review. Lancet Neurology, 5, 64-74. doi: 10.1016/S1474-4422(05)70284-2
4. Buscemi, N., et al. (2007). The efficacy and safety of drug treatments for chronic insomnia in adults: a meta-Analysis of RCTs. Journal of General Internal Medicine, 22, 1335-1350. doi: 10.1007/s11606-007-0251-z.
5. Crosby-Nwaobi, R., Sivaprasad, S. and Forbes, A. (2012) A systematic review of the association of diabetic retinopathy and cognitive impairment in people with Type 2 diabetes. Diabetes Research and Clinical Practice, 96, 101-110. doi: 10.1016/j.diabres.2011.11.010
6. Cukierman, T., Gerstein, H. C. and Williamson, J. D. (2005). Cognitive decline and dementia in diabetes-systematic overview of prospective observational studies. Diabetologia, 48, 2460-2469. doi: 10.1007/s00125-005-0023-4
7. Cumming, R. G. and Le Couteur, D. G. (2003). Benzodiazepines and risk of hip fractures in older people: a review of the evidence. CNS Drugs, 17, 825-837
8. Euser, S. M., Schram, M. T., Hofman, A., Westendorp, R. G. and Breteler, M. M. (2008). Measuring cognitive function with age: the influence of selection by health and survival. Epidemiology, 19, 440-447. doi: 10.1097/EDE.0b013e31816a1d31
9. Folstein, M. F., Folstein, S. E. and McHugh, P. R. (1975). " Mini-mental state": A practical method for grading the cognitive state of patients for the clinician. Journal of Psychiatric Research, 12, 189-198
10. Glass, J., Lanctot, K. L., Herrmann, N., Sproule, B. A. and Busto, U. E. (2005). Sedative hypnotics in older people with insomnia: meta-Analysis of risks and benefits. BMJ, 331, 1169. doi: 10.1136/bmj.38623.768588.47
11. Grad, R. M. (1995). Benzodiazepines for insomnia in community-dwelling elderly: a review of benefit and risk. The Journal of Family Practice, 41, 473-481
12. Gray, S. L., et al. (2006). Benzodiazepine use and physical disability in community-dwelling older adults. Journal of the American Geriatrics Society, 54, 224-230. doi: 10.1111/j.1532-5415.2005.00571.x.
13. Guo, L. W., Liu, H. C. and Wong, P. F. (1988). Chinese version and norms of Mini-Mental State Examination. Journal of Chinese Rehabilitation Medicine, 16, 52-59
14. Holbrook, A. M., Crowther, R., Lotter, A., Cheng, C. and King, D. (2000). Meta-Analysis of benzodiazepine use in the treatment of insomnia. CMAJ, 162, 225-233
15. Katz, S. and Akpom, C. A. (1976) A measure of primary sociobiological functions. International Journal of Health Services: Planning, Administration, Evaluation, 6, 493-508
16. Knopman, D. S., Mosley, T. H., Catellier, D. J., Coker, L. H. and Atherosclerosis Risk in Communities Study Brain, M. R. I. S. (2009). Fourteen-year longitudinal study of vascular risk factors, APOE genotype, and cognition: the ARIC MRI Study. Alzheimer's & Dementia, 5, 207-214. doi: 10.1016/j.jalz.2009.01.027
17. Lai, H. Y., Hwang, S. J., Chen, Y. C., Chen, T. J., Lin, M. H. and Chen, L. K. (2009). Prevalence of the prescribing of potentially inappropriate medications at ambulatory care visits by elderly patients covered by the Taiwanese National Health Insurance program. Clinical Therapeutics, 31, 1859-1870. doi: 10.1016/j.clinthera.2009.08.023
18. Lawton, M. P. and Brody, E.M. (1969). Assessment of older people: self-maintaining and instrumental activities of daily living. The Gerontologist, 9, 179-186
19. Liu, C. K. (2006). The epidemiology of dementia in Taiwan. Acta Neurologica Taiwanica, 15, 51-52
20. Liu, H. C., et al. (1995). Prevalence and subtypes of dementia in Taiwan: a community survey of 5297 individuals. Journal of the American Geriatrics Society, 43, 144-149
21. Luchsinger, J. A., Reitz, C., Patel, B., Tang, M. X., Manly, J. J. and Mayeux, R. (2007). Relation of diabetes to mild cognitive impairment. Archives of Neurology, 64, 570-575. doi: 10.1001/archneur.64.4.570
22. Nowell, P. D., Mazumdar, S., Buysse, D. J., Dew, M. A., Reynolds, C. F., 3rd and Kupfer, D. J. (1997). Benzodiazepines and zolpidem for chronic insomnia: a meta-Analysis of treatment efficacy. JAMA, 278, 2170-2177
23. Petersen, R. C., Smith, G. E., Waring, S. C., Ivnik, R. J., Tangalos, E. G. and Kokmen, E. (1999). Mild cognitive impairment: clinical characterization and outcome. Archives of Neurology, 56, 303-308
24. Ryan, C. M. andGeckle, M. O. (2000). Circumscribed cognitive dysfunction in middle-Aged adults with type 2 diabetes. Diabetes Care, 23, 1486-1493
25. Stewart, R. and Liolitsa, D. (1999). Type 2 diabetes mellitus, cognitive impairment and dementia. Diabetic Medicine, 16, 93-112
26. Strachan, M. W., Deary, I. J., Ewing, F. M. and Frier, B. M. (1997). Is type II diabetes associated with an increased risk of cognitive dysfunction? A critical review of published studies. Diabetes Care, 20, 438-445
27. Strachan, M. W., Frier, B.M. and Deary, I. J. (2003). Type 2 diabetes and cognitive impairment. Diabetic Medicine, 20, 1-2
28. Strachan, M. W., Price, J. F. and Frier, B. M. (2008). Diabetes, cognitive impairment, and dementia. BMJ, 336, 6. doi: 10.1136/bmj.39386.664016.BE.
29. Sussman, M. B. and Association, A. S. (1966). Sociology and Rehabilitation. Chicago, IL: American Sociological Association
30. Tamblyn, R. M., et al. (1994). Questionable prescribing for elderly patients in Quebec. CMAJ, 150, 1801-1809
31. Verdelho, A., et al. (2007). Differential impact of cerebral white matter changes, diabetes, hypertension and stroke on cognitive performance among non-disabled elderly. The LADIS study. Journal of Neurology, Neurosurgery, and Psychiatry, 78, 1325-1330. doi: 10.1136/jnnp.2006.110361
32. Wild, S., Roglic, G., Green, A., Sicree, R. and King, H. (2004). Global prevalence of diabetes: estimates for the year 2000 and projections for 2030. Diabetes Care, 27, 1047-1053
33. Yen, C. H., et al. (2010). Determinants of cognitive impairment over time among the elderly in Taiwan: results of the national longitudinal study. Archives of Gerontology and Geriatrics, 50 (Suppl 1), S53-S57. doi: 10.1016/S0167-4943(10)70014-5